FluoroPharma Medical Inc - ESG Rating & Company Profile powered by AI
This webpage contains a zero-cost E,S&G report covering FluoroPharma Medical Inc. Other corporations in the rating industry group for FluoroPharma Medical Inc are shown. This dashboard contains a Q&A table for FluoroPharma Medical Inc.
FluoroPharma Medical Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | FluoroPharma Medical Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does FluoroPharma Medical Inc have an accelerator or VC vehicle to help deliver innovation?
Does FluoroPharma Medical Inc disclose current and historical energy intensity?
Does FluoroPharma Medical Inc report the average age of the workforce?
Does FluoroPharma Medical Inc reference operational or capital allocation in relation to climate change?
Does FluoroPharma Medical Inc disclose its ethnicity pay gap?
Does FluoroPharma Medical Inc disclose cybersecurity risks?
Does FluoroPharma Medical Inc offer flexible work?
Does FluoroPharma Medical Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does FluoroPharma Medical Inc disclose the number of employees in R&D functions?
Does FluoroPharma Medical Inc conduct supply chain audits?
Does FluoroPharma Medical Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does FluoroPharma Medical Inc conduct 360 degree staff reviews?
Does FluoroPharma Medical Inc disclose the individual responsible for D&I?
Does FluoroPharma Medical Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does FluoroPharma Medical Inc disclose current and / or historical scope 2 emissions?
Does FluoroPharma Medical Inc disclose water use targets?
Does FluoroPharma Medical Inc have careers partnerships with academic institutions?
Did FluoroPharma Medical Inc have a product recall in the last two years?
Does FluoroPharma Medical Inc disclose incidents of discrimination?
Does FluoroPharma Medical Inc allow for Work Councils/Collective Agreements to be formed?
Has FluoroPharma Medical Inc issued a profit warning in the past 24 months?
Does FluoroPharma Medical Inc disclose parental leave metrics?
Does FluoroPharma Medical Inc disclose climate scenario or pathway analysis?
Does FluoroPharma Medical Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does FluoroPharma Medical Inc disclose the pay ratio of women to men?
Does FluoroPharma Medical Inc support suppliers with sustainability related research and development?
Does FluoroPharma Medical Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does FluoroPharma Medical Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is FluoroPharma Medical Inc involved in embryonic stem cell research?
Does FluoroPharma Medical Inc disclose GHG and Air Emissions intensity?
Does FluoroPharma Medical Inc disclose its waste policy?
Does FluoroPharma Medical Inc report according to TCFD requirements?
Does FluoroPharma Medical Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does FluoroPharma Medical Inc disclose energy use targets?
Does FluoroPharma Medical Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does FluoroPharma Medical Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for FluoroPharma Medical Inc
These potential risks are based on the size, segment and geographies of the company.
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.